A new trading day began on Friday, with Chromadex Corp (NASDAQ: CDXC) stock price down -5.28% from the previous day of trading, before settling in for the closing price of $7.20. CDXC’s price has ranged from $1.32 to $7.58 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Consumer Defensive Sector giant saw their annual sales surged by 22.27% over the last five years. Meanwhile, its annual earnings per share averaged 157.14%. With a float of $48.21 million, this company’s outstanding shares have now reached $74.98 million.
The firm has a total of 106 workers. Let’s measure their productivity. In terms of profitability, gross margin is 55.76%, operating margin of 2.42%, and the pretax margin is 1.47%.
Chromadex Corp (CDXC) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Packaged Foods Industry. The insider ownership of Chromadex Corp is 36.88%, while institutional ownership is 23.27%. The most recent insider transaction that took place on Aug 23 ’24, was worth 82,110. In this transaction Director of this company sold 23,000 shares at a rate of $3.57, taking the stock ownership to the 0 shares. Before that another transaction happened on Aug 23 ’24, when Company’s affiliate proposed sale 23,000 for $3.69, making the entire transaction worth $84,810.
Chromadex Corp (CDXC) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of 0 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.02 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 157.14% per share during the next fiscal year.
Chromadex Corp (NASDAQ: CDXC) Trading Performance Indicators
Here are Chromadex Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.35. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.38. Likewise, its price to free cash flow for the trailing twelve months is 124.29.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.02, a number that is poised to hit 0.02 in the next quarter and is forecasted to reach 0.13 in one year’s time.
Technical Analysis of Chromadex Corp (CDXC)
Analysing the last 5-days average volume posted by the [Chromadex Corp, CDXC], we can find that recorded value of 1.31 million was better than the volume posted last year of 0.53 million. As of the previous 9 days, the stock’s Stochastic %D was 76.81%. Additionally, its Average True Range was 0.48.
During the past 100 days, Chromadex Corp’s (CDXC) raw stochastic average was set at 85.31%, which indicates a significant increase from 81.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 222.27% in the past 14 days, which was higher than the 104.92% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.20, while its 200-day Moving Average is $3.23. Now, the first resistance to watch is $7.03. This is followed by the second major resistance level at $7.25. The third major resistance level sits at $7.36. If the price goes on to break the first support level at $6.70, it is likely to go to the next support level at $6.59. Should the price break the second support level, the third support level stands at $6.37.
Chromadex Corp (NASDAQ: CDXC) Key Stats
With a market capitalization of 493.44 million, the company has a total of 76,383K Shares Outstanding. Currently, annual sales are 83,570 K while annual income is -4,940 K. The company’s previous quarter sales were 25,580 K while its latest quarter income was 1,880 K.
